Month: July 2021

How scientific expertise, funding and entrepreneurship came together for the development of an antibody-drug conjugate targeting lymphoma. Oncologists treating diffuse large B-cell lymphoma (DLBCL) have a new medicine in their armoury. In April 2021, following impressive Phase 1 and 2 clinical trial data, the FDA gave accelerated approval to Zynlonta for treating patients with refractory
0 Comments
The coronavirus disease 2019 (COVID-19) pandemic, caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), is strange in the breadth of severity in its clinical manifestations, ranging from asymptomatic to fatal infection. The ability to predict severe disease and thus intervene early is important, and has spurred the search for markers of this shift. An
0 Comments
FDA Approves Rylaze for the Treatment of Acute Lymphoblastic Leukemia or Lymphoblastic Lymphoma DUBLIN, June 30, 2021 /PRNewswire/ — Jazz Pharmaceuticals plc (Nasdaq: JAZZ) today announced the U.S. Food and Drug Administration (FDA) approval of Rylaze (asparaginase erwinia chrysanthemi (recombinant)-rywn) for use as a component of a multi-agent chemotherapeutic regimen for the treatment of acute
0 Comments
July 1, 2021 Audience: Health Professional, Pharmacy July 1, 2021 — Teva Pharmaceuticals has initiated a voluntary recall of lot 31328962B of Topotecan Injection 4 mg/4 mL (1 mg/mL), to the retail/institutional level in the United States. This voluntary recall was initiated based on a complaint received from a pharmacy after a single glass particle
0 Comments
The hashtag #BigHoopEnergy has sparked an online conversation about how women of color in the medical field are pressured to conform to traditional standards of professional appearance. It started when a Latina doctor tweeted that she lost points on a practical exam in medical school because of her hoop earrings, with the evaluator writing “earrings,
0 Comments
Dr. Scott Gottlieb told CNBC on Friday that most Americans should feel comfortable safely gathering over Independence Day weekend, citing high Covid vaccination rates and low virus infection levels in many parts of the country. However, the former Food and Drug Administration commissioner said there are certain places where people should be more careful. “There’s very low
0 Comments
A new report finds that 509,025 (9.17%) public high school students in 24 states experienced homelessness in spring 2019 — three times the number recognized by the states’ education agencies. This under-recognition creates gaps in funding and services needed by this vulnerable population. Researchers from Nemours Children’s Health and the University of Pennsylvania analyzed data
0 Comments
On top of a historic heat wave, the Pacific Northwest has been hit with a rise in COVID-19 cases caused by the Alpha, Delta, and Gamma variants. And while much of the world is focused on Delta, or B.1.617.2, government officials in Washington state are particularly wary of Gamma (P.1). Washington state’s leading COVID-19 strain
0 Comments
What can you do when rejection feels utterly unbearable? Here we explore rejection sensitive dysphoria and its ties to ADHD No one likes to be rejected, do they? As humans, we’ve evolved to fear social rejection – back when we lived in caves, we needed the support of our tribe to stay alive. If we
0 Comments
A proposed rapid diagnostic test for hepatitis C viral infections that combines an inexpensive but lower-sensitivity core-antigen test with lab RNA confirmation of negative tests could expand testing and same-day initiation of antiviral therapy in places where resources are limited, investigators said. Applying the proposed method to the Republic of Georgia, with a hepatitis C
0 Comments
INDIANAPOLIS, June 26, 2021 /PRNewswire/ – Tirzepatide led to superior A1C and body weight reductions from baseline across all three doses in adults with type 2 diabetes after 40 weeks of treatment in Eli Lilly and Company’s (NYSE: LLY) SURPASS-1 monotherapy clinical trial evaluating the efficacy and safety of tirzepatide compared to placebo. Detailed SURPASS-1 results were presented
0 Comments
FDA Approves Rylaze (asparaginase erwinia chrysanthemi (recombinant)-rywn) for the Treatment of Acute Lymphoblastic Leukemia or Lymphoblastic Lymphoma DUBLIN, June 30, 2021 /PRNewswire/ — Jazz Pharmaceuticals plc (Nasdaq: JAZZ) today announced the U.S. Food and Drug Administration (FDA) approval of Rylaze (asparaginase erwinia chrysanthemi (recombinant)-rywn) for use as a component of a multi-agent chemotherapeutic regimen for
0 Comments
The opioid prescription rates have significantly decreased for children, teens, and younger adults between 2006 and 2018, according to new research. “What’s important about this new study is that it documented that these improvements were also occurring for children and young adults specifically,” said Kao-Ping Chua, MD, PhD, primary care physician and assistant professor of
0 Comments
Thought LeadersProfessor Simon DaviesProfessor Raymond Vanholder In this interview, News-Medical speaks to Professor Simon Davies and Professor Raymond Vanholder about the impact of COVID-19 on kidney dialysis patients. Please could you introduce yourself and tell us about your expertise within kidney disease and dialysis? Simon: I have been working in the field of kidney disease
0 Comments
ZED1227, a potential therapeutic transglutaminase 2 inhibitor, reduced mucosal damage from gluten in celiac disease patients, a randomized proof-of-concept trial found. At week 6, the difference in villus height-to-crypt depth average ratio, a measurement of intestinal injury, was significant at three different dosages of ZED1227 (10 mg, 50 mg, and 100 mg) compared to placebo,
0 Comments
Diabetes was more prevalent among lower-income populations from 2001-2018, particularly for females and people ages 45-64, according to a CDC study. Assessing income-related inequalities using the Concentration Index indicated that diabetes was concentrated among low-income groups across the 18-year study period, reported Yu Chen, PhD, of the National Center for Chronic Disease Prevention and Health
0 Comments
This story was originally shared on The Animal Rescue Site. Submit your own rescue story here. Your story just might be the next to be featured on our blog! I wanted a chihuahua to be a companion to a small one I have that has seizures and sight problems. I thought a friend would help
0 Comments
We’re told getting things off our chest will make us feel better in the long run, but what should we do if we initially feel worse? Opening up and reaching out for support is a hugely important part of working through mental health problems – both big and small. And it can often bring a
0 Comments
Older adults with hearing impairment tend to have poorer physical function, less walking endurance, and faster declines in physical function compared with older adults with normal hearing, according to a study published online in JAMA Network Open. Hearing loss is associated with slower gait and, in particular, worse balance, the data suggest. “Because hearing impairment
0 Comments